Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  HISTORICAL VOLUME
Historical Volume      
Alembic Pharmaceuticals Ltd.
BSE Code 533573
ISIN Demat INE901L01018
Book Value 255.98
NSE Code APLLTD
Dividend Yield % 1.04
Market Cap 207374.10
P/E 26.69
EPS 39.53
Face Value 2  
Exchange : Period From : Period To :
DateOpen Price(Rs.)High Price(Rs.)Low Price(Rs.)Close Price(Rs.)VolumeTurnover
20-Dec-2024 1047.00 1081.10 1047.00 1055.00 7304 7753150
19-Dec-2024 1069.95 1069.95 1044.00 1050.15 3234 3416504
18-Dec-2024 1036.40 1071.75 1036.40 1056.00 5501 5783895
17-Dec-2024 1050.00 1059.15 1032.05 1035.75 1560 1626458
16-Dec-2024 1042.15 1081.40 1042.15 1054.60 2784 2972199
13-Dec-2024 1034.00 1066.00 1034.00 1061.35 5971 6311381
12-Dec-2024 1097.90 1100.00 1031.10 1046.45 16865 17833846
11-Dec-2024 1096.05 1104.10 1084.80 1092.20 5983 6531669
10-Dec-2024 1112.90 1117.40 1094.90 1103.75 6399 7076555
09-Dec-2024 1084.85 1109.80 1072.00 1103.20 4034 4398648
06-Dec-2024 1090.00 1090.00 1071.00 1084.25 4624 4993059
05-Dec-2024 1094.95 1100.75 1076.85 1087.00 5788 6298789
04-Dec-2024 1103.00 1122.25 1091.00 1094.90 5267 5822559
03-Dec-2024 1110.00 1112.95 1096.00 1100.40 2493 2751960
02-Dec-2024 1070.40 1108.10 1070.40 1102.40 2400 2627136
Page 1 of 1
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.